Utah Medical Products, Inc. - UTMD

UTMD Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
UTMD	-0.4	-1.7	-0.5	-3.0	-4.3	-22.7	-40.1	-33.6	10.7	6034.3
S&P 500	-1.4	-1.8	0.9	5.8	10.5	30.3	25.3	88.0	187.4	33118.2

Compare UTMD with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	UTMD
name	Utah Medical Products, Inc.
price	66.25
changes percentage	-0.4059
change	-0.27
day low	65.528
day high	67.6002
year high	87.21
year low	63.38
market cap	224694825
price avg 50	66.0334
price avg 200	68.24715
exchange	NASDAQ
volume	9010
avg volume	20281
open	66.78
previous close	66.52
eps	4.28
pe	15.48
earnings announcement	2025-01-28T05:00:00.000+0000
shares outstanding	3391620
timestamp	2024-11-15 18:25:15

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 63.0%

Overall Quarterly Financial Health: 41.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000706698
revenue	50224000	52281000	-3.93
gross profit	30038000	32196000	-6.70
gross profit ratio	0.6	0.62	-2.88
research and development expenses	560000	493000	13.59
operating expenses	13261000	12406000	6.89
interest income	0	661000	-100.00
interest expense	0	-869000	100.00
ebitda	24805000	26872000	-7.69
ebitdaratio	0.49	0.38	30.47
operating income	16777000	12708000	32.02
operating income ratio	0.33	0.24	37.43
net income	16635000	16473000	0.98
net income ratio	0.33	0.32	5.12
eps	4.57	4.53	0.88

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 50 million in 2023 from 52 million in 2022 representing a change of -3.93%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 30 million in 2023 from 32 million in 2022 representing a change of -6.7%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 13 million in 2023 from 12 million in 2022 representing a change of 6.89%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 25 million in 2023 from 27 million in 2022 representing a change of -7.69%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 1 million in 2023 from 0 million in 2022 representing a change of 13.59%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 17 million in 2023 from 13 million in 2022 representing a change of 32.02%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 17 million in 2023 from 16 million in 2022 representing a change of 0.98%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 4.57 in 2023 from 4.57 in 2022 representing a change of 0.88%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000706698
revenue	10005000	10400000	-3.80
gross profit	5277000	5744000	-8.13
gross profit ratio	0.53	0.55	-4.50
research and development expenses	172000	255000	-32.55
operating expenses	2459000	2306000	6.63
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	4907000	3438000	42.73
ebitdaratio	0.49	0.4	23.83
operating income	3343000	3438000	-2.76
operating income ratio	0.33	0.33	1.08
net income	3564000	3453000	3.21
net income ratio	0.36	0.33	7.29
eps	1.02	0.95	7.37

Overall Score of Quarterly Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 10 million in 2024Q3 from 10 million in 2024Q2 representing a change of -3.8%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 5 million in 2024Q3 from 6 million in 2024Q2 representing a change of -8.13%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q3 from 0 million in 2024Q2 representing a change of -32.55%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 2 million in 2024Q3 from 2 million in 2024Q2 representing a change of 6.63%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 3 million in 2024Q3 from 3 million in 2024Q2 representing a change of -2.76%. The decrease in operating income indicates worse operational performance and decreased profitability.

• 📈 Positive Indicators

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 5 million in 2024Q3 from 3 million in 2024Q2 representing a change of 42.73%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 4 million in 2024Q3 from 3 million in 2024Q2 representing a change of 3.21%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.02 in 2024Q3 from 1.02 in 2024Q2 representing a change of 7.37%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000706698
total assets	135458000	123874000	9.35
total liabilities	7145000	9619000	-25.72
total equity	128312999	114255000	12.30
cash and cash equivalents	92868000	75052000	23.74
short term investments	185738000	0	NaN
long term investments	0	0	NaN
total current assets	106269000	89919000	18.18
total non current assets	29189000	33955000	-14.04
total current liabilities	4710000	5753000	-18.13
total non current liabilities	2435001	3866000	-37.01
common stock	36000	36000	0.00
retained earnings	138341000	126006000	9.79
total debt	342000	341000	0.29

Overall Score of Annual Balance Sheet

0.89 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 135 million in 2023 from 124 million in 2022 representing a change of 9.35%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 7 million in 2023 from 10 million in 2022 representing a change of -25.72%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 128 million in 2023 from 114 million in 2022 representing a change of 12.3%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 93 million in 2023 from 75 million in 2022 representing a change of 23.74%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 186 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 106 million in 2023 from 90 million in 2022 representing a change of 18.18%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 5 million in 2023 from 6 million in 2022 representing a change of -18.13%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 138 million in 2023 from 126 million in 2022 representing a change of 9.79%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Debt: Total Debt increased to 0 million in 2023 from 0 million in 2022 representing a change of 0.29%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000706698
total assets	129694000	130032000	-0.26
total liabilities	5497000	5980000	-8.08
total equity	124197000	124052000	0.12
cash and cash equivalents	88452000	89219000	-0.86
short term investments	0	178438000	-100.00
long term investments	0	-17724000	100.00
total current assets	101656000	102322000	-0.65
total non current assets	28038000	27710000	1.18
total current liabilities	3435000	3939000	-12.80
total non current liabilities	2062000	2041000	1.03
common stock	34000	35000	-2.86
retained earnings	134053000	135339000	-0.95
total debt	299000	275000	8.73

Overall Score of Quarterly Balance Sheet

0.3 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 130 million in 2024Q3 from 130 million in 2024Q2 representing a change of -0.26%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 88 million in 2024Q3 from 89 million in 2024Q2 representing a change of -0.86%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 0 million in 2024Q3 from 178 million in 2024Q2 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 102 million in 2024Q3 from 102 million in 2024Q2 representing a change of -0.65%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 0 in 2024Q3 from 0 in 2024Q2 representing a change of -2.86%. This indicates a decrease in ownership interest.

  Retained Earnings: Retained Earnings decreased to 134 million in 2024Q3 from 135 million in 2024Q2 representing a change of -0.95%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 0 million in 2024Q3 from 0 million in 2024Q2 representing a change of 8.73%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 5 million in 2024Q3 from 6 million in 2024Q2 representing a change of -8.08%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 124 million in 2024Q3 from 124 million in 2024Q2 representing a change of 0.12%. This indicates an increase in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities decreased to 3 million in 2024Q3 from 4 million in 2024Q2 representing a change of -12.8%. This indicates a lower short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000706698
net change in cash	17816000	14078000	26.55
operating cash flow	22281000	21147000	5.36
free cash flow	21642000	20329000	6.46
capital expenditure	-639000	-818000	21.88
depreciation and amortization	6368000	7082000	-10.08
deferred income tax	-693000	-401000	-72.82
stock based compensation	225000	183000	22.95
accounts payables	-456000	464000	-198.28
inventory	-670000	-2353000	71.53
acquisitions net	0	0	NaN
investments in property plant and equipment	-639000	-818000	21.88
net cash used for investing activites	-639000	-818000	21.88
debt repayment	0	0	NaN
common stock issued	117000	174000	-32.76
common stock repurchased	-2495000	-2495000	0.00
dividends paid	-4282000	-3163000	-35.38
net cash used provided by financing activities	-4165000	-5484000	24.05
cash at end of period	92868000	75052000	23.74
accounts receivables	2270000	-511000	544.23
cash at beginning of period	75052000	60974000	23.09

Overall Score of Annual Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 18 million in 2023 from 14 million in 2022 representing a change of 26.55%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 22 million in 2023 from 21 million in 2022 representing a change of 5.36%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 22 million in 2023 from 20 million in 2022 representing a change of 6.46%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 0 million in 2022 representing a change of -198.28%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -1 million in 2023 from -1 million in 2022 representing a change of 21.88%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 0 million in 2023 from 0 million in 2022 representing a change of 22.95%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 2 in 2023 from -1 million in 2022 representing a change of 544.23%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -4 million in 2023 from -3 million in 2022 representing a change of -35.38%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000706698
operating cash flow	3856000	2762000	39.61
free cash flow	3993000	2647000	50.85
capital expenditure	137000	-115000	219.13
depreciation and amortization	-808000	693000	-216.59
deferred income tax	-53000	-161000	67.08
stock based compensation	53000	52000	1.92
accounts receivables	291000	-83000	450.60
accounts payables	163000	-164000	199.39
inventory	67000	170000	-60.59
acquisitions net	-27000	0	NaN
investments in property plant and equipment	137000	-110000	224.55
net cash used for investing activites	-89000	-115000	22.61
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-3866000	-6403000	39.62
dividends paid	-1052000	-1081000	2.68
net cash used provided by financing activities	-4918000	-7190000	31.60
net change in cash	-767000	-4589000	83.29
cash at end of period	88452000	89219000	-0.86
cash at beginning of period	89219000	93808000	-4.89

Overall Score of Quarterly Cashflow Statement

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -1 million in 2024Q3 from -5 million in 2024Q2 representing a change of 83.29%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 4 million in 2024Q3 from 3 million in 2024Q2 representing a change of 39.61%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 4 million in 2024Q3 from 3 million in 2024Q2 representing a change of 50.85%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q3 from 0 million in 2024Q2 representing a change of 199.39%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid increased to -1 million in 2024Q3 from -1 million in 2024Q2 representing a change of 2.68%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to 0 million in 2024Q3 from 0 million in 2024Q2 representing a change of 219.13%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2024Q3 from 0 million in 2024Q2 representing a change of 67.08%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 0 million in 2024Q3 from 0 million in 2024Q2 representing a change of 1.92%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 0 in 2024Q3 from 0 million in 2024Q2 representing a change of 450.6%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	13.81	14.37	-3.93
net income per share	4.57	4.53	0.99
operating cash flow per share	6.13	5.81	5.37
free cash flow per share	5.95	5.59	6.46
cash per share	76.61	20.64	271.23
book value per share	35.28	31.41	12.31
tangible book value per share	30.16	25.0	20.63
shareholders equity per share	35.28	31.41	12.31
interest debt per share	0	-0.24	100.00
market cap	306296349.2	365627610	-16.23
enterprise value	213770349.2	290916610	-26.52
pe ratio	18.41	22.2	-17.04
price to sales ratio	6.1	6.99	-12.80
pocfratio	13.75	17.29	-20.49
pfcf ratio	14.15	17.99	-21.31
pb ratio	2.39	3.2	-25.41
ptb ratio	2.39	3.2	-25.41
ev to sales	4.26	5.56	-23.51
enterprise value over ebitda	8.62	10.83	-20.40
ev to operating cash flow	9.59	13.76	-30.26
ev to free cash flow	9.88	14.31	-30.98
earnings yield	0.05	0.05	20.54
free cash flow yield	0.07	0.06	27.08
debt to equity	0	0	NaN
debt to assets	0	0	NaN
net debt to ebitda	-3.73	-2.78	-34.17
current ratio	22.56	15.63	44.35
interest coverage	0	-14.62	100.00
income quality	1.34	1.28	4.34
dividend yield	0.01	0.01	61.60
payout ratio	0.26	0.19	34.06
sales general and administrative to revenue	0.22	0.2	10.20
research and ddevelopement to revenue	0.01	0.01	18.24
intangibles to total assets	0.14	0.19	-26.96
capex to operating cash flow	0.03	0.04	-25.86
capex to revenue	0.01	0.02	-18.68
capex to depreciation	0.1	0.12	-13.12
stock based compensation to revenue	0.0	0.0	27.99
graham number	60.26	56.58	6.50
roic	0.11	0.09	22.08
return on tangible assets	0.14	0.16	-13.09
graham net net	76.66	20.34	276.80
working capital	101559000	84166000	20.67
tangible asset value	109675000	90919000	20.63
net current asset value	99124000	80300000	23.44
invested capital	130748000	118121000	10.69
average receivables	4464500	5335000	-16.32
average payables	993500	989500	0.40
average inventory	9198000	7705000	19.38
days sales outstanding	24.64	38.66	-36.26
days payables outstanding	13.9	22.13	-37.18
days of inventory on hand	173.26	160.17	8.17
receivables turnover	14.81	9.44	56.89
payables turnover	26.25	16.49	59.18
inventory turnover	2.11	2.28	-7.55
roe	0.13	0.14	-10.08
capex per share	0.18	0.22	-21.88

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 18.41 on 2023-12-31 from 22.20 on 2022-12-31, representing a change of -17.04%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 22.56 on 2023-12-31 from 15.63 on 2022-12-31, representing a change of 44.35%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
UTMD
calendar year	2024	2024	NaN
revenue per share	2.88	2.87	0.11
net income per share	1.02	0.95	7.41
operating cash flow per share	1.11	0.76	45.28
free cash flow per share	1.15	0.73	56.98
cash per share	25.43	73.95	-65.61
book value per share	35.71	34.27	4.19
tangible book value per share	30.64	29.43	4.11
shareholders equity per share	35.71	34.27	4.19
interest debt per share	0	0	NaN
market cap	232712980	241015579.64	-3.44
enterprise value	144559980	152071579.64	-4.94
pe ratio	16.32	17.45	-6.45
price to sales ratio	23.26	23.17	0.37
pocfratio	60.35	87.26	-30.84
pfcf ratio	58.28	91.05	-35.99
pb ratio	1.87	1.94	-3.56
ptb ratio	1.87	1.94	-3.56
ev to sales	14.45	14.62	-1.19
enterprise value over ebitda	29.46	44.23	-33.40
ev to operating cash flow	37.49	55.06	-31.91
ev to free cash flow	36.2	57.45	-36.98
earnings yield	0.02	0.01	6.90
free cash flow yield	0.02	0.01	56.23
debt to equity	0	0	NaN
debt to assets	0	0	NaN
net debt to ebitda	-17.96	-25.87	30.56
current ratio	29.59	25.98	13.93
interest coverage	0	0	NaN
income quality	1.08	0.8	35.30
dividend yield	0.0	0.0	0.79
payout ratio	0.3	0.31	-5.71
sales general and administrative to revenue	0	0.19	-100.00
research and ddevelopement to revenue	0.02	0.02	-29.89
intangibles to total assets	0.14	0.13	0.85
capex to operating cash flow	0.04	0.04	-14.67
capex to revenue	0.01	0.01	23.83
capex to depreciation	-0.17	0.17	-202.17
stock based compensation to revenue	0.01	0.01	5.95
graham number	28.69	27.12	5.79
roic	0.02	0.02	1.01
return on tangible assets	0.03	0.03	3.62
graham net net	25.96	74.31	-65.06
working capital	98221000	98383000	-0.16
tangible asset value	106578000	106536000	0.04
net current asset value	96159000	96342000	-0.19
invested capital	126259000	126093000	0.13
average receivables	3694000	3629500	1.78
average payables	916500	916000	0.05
average inventory	9082500	9149000	-0.73
days sales outstanding	33.46	31.74	5.42
days payables outstanding	19.02	16.12	17.96
days of inventory on hand	173.36	175.09	-0.99
receivables turnover	2.69	2.84	-5.14
payables turnover	4.73	5.58	-15.23
inventory turnover	0.52	0.51	1.00
roe	0.03	0.03	3.09
capex per share	0.04	0.03	23.97

• Negative

  ROE: Return on Equity (ROE) decreased to 0.03 on 2024-09-30 Q3 from 0.03 on 2024-06-30 Q2, representing a change of 3.09%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 16.32 on 2024-09-30 Q3 from 17.45 on 2024-06-30 Q2, representing a change of -6.45%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 29.59 on 2024-09-30 Q3 from 25.98 on 2024-06-30 Q2, representing a change of 13.93%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 126.38 which is higher than current price 66.25, indicates the company may be undervalued.